Cyclosporin

Fülszöveg

About the Book Here is a comprehensive, up-to-date and balanced account of this major drug, which has revolutionized transplantation medicine and is being increasingly used in other major areas of therapy. Cyclosporin is a potent immunosuppressive agent acting against cells involved in the immuné response. Widely used in the treatment of rejection after transplantation, it is likely to prove valuable in the treatment of autoimmune diseases such as those involving the skin (psoriasis), eyes (uveitis) and pancreas (insulin-dependent diabetes). Three broad sections of the book cover the mechanism of action of cyclosporin, its clinical application in transplantation and autoimmune disease and its pharmacology and pathology in both experimentál systems and clinical practice. Thus this volume provides both a generál review of the basic science and clinical aspects of cyclosporin for those requiring a detailed introduction to the drug, as well as covering the most recent developments in... Tovább

Fülszöveg

About the Book Here is a comprehensive, up-to-date and balanced account of this major drug, which has revolutionized transplantation medicine and is being increasingly used in other major areas of therapy. Cyclosporin is a potent immunosuppressive agent acting against cells involved in the immuné response. Widely used in the treatment of rejection after transplantation, it is likely to prove valuable in the treatment of autoimmune diseases such as those involving the skin (psoriasis), eyes (uveitis) and pancreas (insulin-dependent diabetes). Three broad sections of the book cover the mechanism of action of cyclosporin, its clinical application in transplantation and autoimmune disease and its pharmacology and pathology in both experimentál systems and clinical practice. Thus this volume provides both a generál review of the basic science and clinical aspects of cyclosporin for those requiring a detailed introduction to the drug, as well as covering the most recent developments in the understanding of the drug's action and applications that have taken place in the last few years. About the Editor Dr Angus W. Thomson is Reader in Immunology at the University of Aberdeen. He trained in Immunology at the University of Birmingham and has been awarded the PhD and DSc degrees by the University of Aberdeen for his work on immunotherapeutic agents. His early studies on the mode of action of cyclosporin were completed whilst holding a Medical Research Council Travelling Fellowship at the Kolling Institute of Medical Research, Royal North Shore Hospitál, Sydney, Australia. He is a member of the Royal College of Pathologists and is presently a committee member of the British Society for Immunology and the British Transplantation Society. He has published widely on cellular immunology and immunopharmacology. Vissza